Illarioshkin S N, Ivanova-Smolenskaya I A, Greenberg C R, Nylen E, Sukhorukov V S, Poleshchuk V V, Markova E D, Wrogemann K
Department of Neurogenetics, Institute of Neurology, Russian Academy of Medical Sciences, Moscow, Russia.
Neurology. 2000 Dec 26;55(12):1931-3. doi: 10.1212/wnl.55.12.1931.
Limb-girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi myopathy (MM) are autosomal recessive disorders caused by mutations in the dysferlin gene on chromosome 2p13. The authors studied a large Russian family with both LGMD2B and MM. All affected individuals, as well as one preclinical boy with dystrophic changes on muscle biopsy, were found to be homozygous for a novel dysferlin mutation, TG573/574AT (Val67Asp). This finding supports the view that additional factors (e.g., modifier genes) contribute to the phenotypic expression of causative mutations in dysferlinopathies.
2B型肢带型肌营养不良症(LGMD2B)和宫下肌病(MM)是由位于2号染色体p13区域的dysferlin基因突变引起的常染色体隐性疾病。作者研究了一个同时患有LGMD2B和MM的俄罗斯大家庭。所有受影响个体,以及一名肌肉活检显示有营养不良变化的临床前男孩,均被发现为一种新的dysferlin基因突变TG573/574AT(Val67Asp)的纯合子。这一发现支持了以下观点,即其他因素(如修饰基因)有助于dysferlin病致病突变的表型表达。